Koninklijke Philips | PHG - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Abbott USD 6.54B 625M 2025-12
Baxter International USD 577M 373M 2025-12
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Boston Scientific USD 3.68B 136M 2025-12
Danaher USD 3.97B 443M 2025-12
Demant DKK 8.82B 277M 2025-12
Dexcom USD 792.7M 61.3M 2025-12
Edwards Lifesciences USD 1.23B 18.7M 2025-12
Fresenius EUR 1.51B 214M 2025-12
General Electric Aerospace USD 3.8B 118M 2025-12
Getinge SEK 5.05B 1.5B 2024-12
Globus Medical USD 535.95M 49.28M 2025-12
GN Store Nord DKK 2.5B 344M 2025-12
Hitachi JPY 809.05B 44.66B 2025-12
Hologic USD 586.4M 2.9M 2025-12
Idexx Laboratories USD 658.11M 25.24M 2025-12
Insulet USD 568.6M 58.5M 2025-12
Integra LifeSciences USD 217.1M 10.11M 2025-12
Intuitive Surgical USD 1.9B 241.9M 2025-12
J&J USD 16.6B 118M 2025-12
Koninklijke Philips EUR 2.29B 378M 2025-12
Masimo USD 247.3M 16.7M 2025-12
Medtronic USD 5.41B 27M 2025-12
Philips EUR 2.29B 377M 2025-12
ResMed USD 878.72M 57.9M 2025-12
Smith & Nephew USD 2.09B 117M 2025-12
Steris USD 655.5M 9.6M 2025-12
Stryker USD 4.49B 633M 2025-12
Teleflex USD 307.45M 144.2M 2025-12
Terumo JPY 153.19B 6.2B 2025-12
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12